Diabetes cell therapies take evasive action
Elie Dolgin • February 25, 2022
Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
Continue reading at Nature Biotechnology.
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.